Skip to main content

BML-288

BML-PD200

1 citation

  • BML-PD200-0025   —   25 mg
    $410.00

Potent (IC50=40nM) and selective (290X selectivity over other PDE isoforms) inhibitor of phosphodiesterase Type II (PDE2). Displayed no significant level of binding to neither a collection of 54 receptors and ion channels, nor to a panel of 30 kinases. BML-288 demonstrated no inhibition of 5-lipoxygenase (5-LO) or cyclooxygenase (COX-1). BML-288 is more potent and selective than EHNA (BML-PD129).

Shipping: Available products typically ship within 24/48h, via priority shipping.

Do you need support? Contact Customer Service or Technical Support.

Online Account
Access or Create Your Account

Regulatory Status

RUO – Research Use Only